Back to search

Article

Multifunctional CRISPR/Cas9 with engineered immunosilenced human T cell epitopes

2018-07-02

Abstract excerpt

The application of Cas9 for genetic and epigenetic therapies in humans raises concerns over immunogenicity of this foreign protein. We report pre-existing human CD8+ T cell immunity to Streptococcus pyogenes Cas9 in the majority of healthy individuals screened. In a proof-of-principle study, we demonstrate that Cas9 protein can be modified to eliminate immunodominant epitopes through targeted mutation while prese...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71d9fad9-8722-5b7a-90df-a2e75cdba66b
DOI
10.1101/360198
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multifunctional CRISPR/Cas9 with engineered immunosilenced human T cell epitopesDOI 10.1101/360198
Select a neighboring publication to make it the new centre.